Leukocare AG
Leukocare AG's Overview
Leukocare AG is a German biotechnology company specializing in advanced formulation development for biopharmaceuticals, including proteins, antibodies, viral vectors for gene therapy, and vaccines. They provide innovative solutions to stabilize complex biological molecules, improving their shelf-life, efficacy, and reducing issues like aggregation or particle formation. Leukocare's proprietary SPS® (Stabilizing and Protecting Solutions) formulation technologies are tailored to protect therapeutic proteins and other biologics throughout their lifecycle, from manufacturing and storage to administration.
Where is Leukocare AG's Headquarters?
HQ Function
Serves as the central hub for research and development, corporate strategy, business development, and administrative operations.
Notable Features:
Located within the Innovation and Start-up Center for Biotechnology (IZB) in Martinsried, one of Europe's leading biotech clusters, offering access to advanced laboratory infrastructure and a collaborative scientific community.
Work Culture:
Characterized by a strong scientific focus, innovation, precision, and collaboration, driven by a mission to advance biopharmaceutical development and improve patient outcomes.
HQ Significance:
Its strategic location in the Martinsried biotech hub provides proximity to top-tier academic research, industry partners, and a skilled talent pool, fostering innovation and growth in biopharmaceutical formulation.
Values Reflected in HQ: The headquarters' setting and state-of-the-art facilities reflect Leukocare's core values of scientific excellence, innovation, quality, and collaboration in developing cutting-edge drug product formulations.
Location:
Leukocare AG serves a global clientele in the pharmaceutical and biotechnology industries. While its primary R&D and corporate functions are based in Germany, its US subsidiary in Massachusetts extends its operational reach and client support across North America. The company engages in international collaborations and provides its specialized formulation development services to partners worldwide, addressing the global need for stable and effective biopharmaceutical products.
Street Address:
Am Klopferspitz 19
City:
Martinsried
State/Province:
Bavaria
Country:
Germany
Leukocare AG's Global Presence
Westborough, Massachusetts, USA
Address: 200 Friberg Parkway, Suite 1002, Westborough, MA 01581, USA
To strengthen Leukocare's footprint in the significant North American market, providing local support and access to its specialized formulation development services for US-based and international clients operating in the region.
Buying Intent Signals for Leukocare AG
Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.
Executive Team of Leukocare AG
As of April 2025, Leukocare AG' leadership includes:
Investors of Leukocare AG
Leukocare AG has been backed by several prominent investors over the years, including:
Executive New Hires/Exits in the Last 12 Months
No major C-level executive hires or departures have been publicly announced by Leukocare AG in the last 12 months. The current leadership team appears to be stable.
Technology (Tech Stack) used by Leukocare AG
Discover the tools Leukocare AG uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.
Leukocare AG Email Formats and Examples
Leukocare AG's email format is believed to commonly follow the pattern of [first_initial].[last_name]@leukocare.com or [first_name].[last_name]@leukocare.com. These are standard conventions in many professional organizations.
f.last@leukocare.com or first.last@leukocare.com
Format
j.doe@leukocare.com or jane.doe@leukocare.com
Example
75%
Success rate
News and media
Leukocare AG Press Release • March 7, 2024
Leukocare AG News: Leukocare and BioNTech expand their collaboration in mRNA vaccine formulation
Leukocare AG and BioNTech SE announced the expansion of their existing collaboration. Under the new agreement, Leukocare will provide advanced formulation development services for a range of BioNTech’s mRNA-based vaccine candidates, building on their previous successful projects....more
Leukocare AG Press Release • October 10, 2023
Leukocare AG News: Leukocare and Nanologica Announce Collaboration to Develop Formulations for Inhaled Biologics
Leukocare AG and Nanologica AB (publ) entered into a collaboration to develop advanced formulations for inhaled biologics. This partnership aims to combine Nanologica’s expertise in porous silica nanoparticles with Leukocare’s proprietary SPS® formulation technologies to enhance the delivery and stability of biopharmaceuticals administered via inhalation....more
Business Wire / Leukocare AG Press Release • January 24, 2023
Leukocare AG News: LEUKOCARE Raises EUR 17.5 Million in Series H Financing Round Led by Petrichor
Leukocare AG announced the successful closing of a EUR 17.5 million Series H financing round. The round was led by Petrichor Healthcare Capital Management, with strong participation from existing investors, aimed at accelerating growth and expanding its US operations....more
Highperformr’s free tools for company research
Explore Employees by Region or Country
See where a company’s workforce is located, by country or region.
View Funding Details
View past and recent funding rounds with amounts and investors.
Understand Revenue Insights
Understand company revenue estimates and financial scale.
Track Active Job Openings
Track active roles and hiring trends to spot growth signals.
Review Product and Offerings
Discover what a company offers—products, platforms, and solutions.
Get SIC or NAICS Codes
Get the company’s official SIC and NAICS classifications.
Analyze Website Traffic Trends
Analyze visitor volume, engagement, and top traffic sources.
Discover Social Profiles and Engagement
Explore LinkedIn, Twitter, and other active social profiles.
Identify Top Competitors
Identify top competitors based on similar business traits.
Research and Discover Companies with Highperformr — Smarter, Faster
Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.
Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.
- Track intent signals to find buyers who are actively in-market
- Enrich contacts and companies instantly, no need to switch tools
- Automate workflows to stay ahead of every change
- Connect your CRM & tools for seamless data sync and activation
Thousands of companies, including Leukocare AG, are just a search away.